BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 28838624)

  • 1. [Systemic inflammatory profile of smokers with and without COPD].
    Mosrane Y; Bougrida M; Alloui AS; Martani M; Rouabah L; Bourahli MK; Mehdioui H; Ben Saad H
    Rev Pneumol Clin; 2017 Sep; 73(4):188-198. PubMed ID: 28838624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic inflammation in patients with COPD and pulmonary hypertension.
    Joppa P; Petrasova D; Stancak B; Tkacova R
    Chest; 2006 Aug; 130(2):326-33. PubMed ID: 16899829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of active smoking on airway and systemic inflammation profiles in patients with chronic obstructive pulmonary disease.
    Pelegrino NR; Tanni SE; Amaral RA; Angeleli AY; Correa C; Godoy I
    Am J Med Sci; 2013 Jun; 345(6):440-5. PubMed ID: 22874622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor necrosis factor receptor 2 as a possible marker of COPD in smokers and ex-smokers.
    Caram LMO; Ferrari R; Nogueira DL; Oliveira M; Francisqueti FV; Tanni SE; Corrêa CR; Godoy I
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2015-2021. PubMed ID: 28744116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex hormone alterations and systemic inflammation in a group of male COPD smokers and their correlation with the +138 insA/delA endothelin-1 gene polymorphism. A case-control study.
    Kaparianos A; Argyropoulou E; Efremidis G; Spiropoulos K
    Eur Rev Med Pharmacol Sci; 2011 Oct; 15(10):1149-57. PubMed ID: 22165675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skin condition and its relationship to systemic inflammation in chronic obstructive pulmonary disease.
    Majewski S; Pietrzak A; Tworek D; Szewczyk K; Kumor-Kisielewska A; Kurmanowska Z; Górski P; Zalewska-Janowska A; Piotrowski WJ
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2407-2415. PubMed ID: 28860735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of patients with chronic obstructive pulmonary disease (COPD) by measurement of plasma biomarkers.
    Shaker SB; von Wachenfeldt KA; Larsson S; Mile I; Persdotter S; Dahlbäck M; Broberg P; Stoel B; Bach KS; Hestad M; Fehniger TE; Dirksen A
    Clin Respir J; 2008 Jan; 2(1):17-25. PubMed ID: 20298300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in systemic inflammation between cigarette and biomass smoke-induced COPD.
    Golpe R; Martín-Robles I; Sanjuán-López P; Pérez-de-Llano L; González-Juanatey C; López-Campos JL; Arellano-Orden E
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2639-2646. PubMed ID: 28979110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Characteristics of stable chronic obstructive pulmonary disease related to systemic inflammation].
    Solanes I; Bolíbar I; Llauger MA; Medrano C; Peiró M; Fraga M; Pou MA; Giner J; Freixas M; Plaza V;
    Med Clin (Barc); 2012 Oct; 139(10):430-6. PubMed ID: 22766062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory parameters and pulmonary biomarkers in smokers with and without chronic obstructive pulmonary disease (COPD).
    Andreeva E; Pokhasnikova M; Lebedev A; Moiseeva I; Kozlov A; Kuznetsova O; Degryse JM
    J Thorac Dis; 2021 Aug; 13(8):4812-4829. PubMed ID: 34527321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of tumor markers and inflammatory biomarkers in chronic obstructive pulmonary disease (COPD) exacerbations.
    Barouchos N; Papazafiropoulou A; Iacovidou N; Vrachnis N; Barouchos N; Armeniakou E; Dionyssopoulou V; Mathioudakis AG; Christopoulou E; Koltsida S; Bassiakou E
    Scand J Clin Lab Invest; 2015 Apr; 75(2):126-32. PubMed ID: 25598350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic inflammation in chronic obstructive pulmonary disease: a population-based study.
    Garcia-Rio F; Miravitlles M; Soriano JB; Muñoz L; Duran-Tauleria E; Sánchez G; Sobradillo V; Ancochea J;
    Respir Res; 2010 May; 11(1):63. PubMed ID: 20500811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic Markers of Inflammation in Smokers With Symptoms Despite Preserved Spirometry in SPIROMICS.
    Garudadri S; Woodruff PG; Han MK; Curtis JL; Barr RG; Bleecker ER; Bowler RP; Comellas A; Cooper CB; Criner G; Dransfield MT; Hansel NN; Paine R; Krishnan JA; Peters SP; Hastie AT; Martinez FJ; O'Neal WK; Couper DJ; Alexis NE; Christenson SA
    Chest; 2019 May; 155(5):908-917. PubMed ID: 30684474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.
    Thomsen M; Ingebrigtsen TS; Marott JL; Dahl M; Lange P; Vestbo J; Nordestgaard BG
    JAMA; 2013 Jun; 309(22):2353-61. PubMed ID: 23757083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exhaled nitric oxide, systemic inflammation, and the spirometric response to inhaled fluticasone propionate in severe chronic obstructive pulmonary disease: a prospective study.
    Kunisaki KM; Rice KL; Janoff EN; Rector TS; Niewoehner DE
    Ther Adv Respir Dis; 2008 Apr; 2(2):55-64. PubMed ID: 19124359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mixed Th2 and non-Th2 inflammatory pattern in the asthma-COPD overlap: a network approach.
    de Llano LP; Cosío BG; Iglesias A; de Las Cuevas N; Soler-Cataluña JJ; Izquierdo JL; López-Campos JL; Calero C; Plaza V; Miravitlles M; Torrego A; Martinez-Moragon E; Soriano JB; Viña AL; Bobolea I
    Int J Chron Obstruct Pulmon Dis; 2018; 13():591-601. PubMed ID: 29483774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of 4-hydroxynonenal in assessment of chronic obstructive pulmonary disease severity].
    Liu H; Xu JY
    Zhonghua Jie He He Hu Xi Za Zhi; 2012 Oct; 35(10):758-61. PubMed ID: 23289993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-reactive protein in patients with COPD, control smokers and non-smokers.
    Pinto-Plata VM; Müllerova H; Toso JF; Feudjo-Tepie M; Soriano JB; Vessey RS; Celli BR
    Thorax; 2006 Jan; 61(1):23-8. PubMed ID: 16143583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarkers of systemic inflammation in stable and exacerbation phases of COPD.
    Karadag F; Karul AB; Cildag O; Yilmaz M; Ozcan H
    Lung; 2008; 186(6):403-9. PubMed ID: 18807087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between serum biomarkers and BODE index in patients with stable COPD.
    Liu SF; Chin CH; Wang CC; Lin MC
    Respirology; 2009 Sep; 14(7):999-1004. PubMed ID: 19740260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.